TCL Archive In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra February 27, 1976
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012